Zheng Quan Zhi Xing·2025-07-04 16:22Core Viewpoint - Shanghai Pharmaceuticals Holding Co., Ltd. has completed the share buyback plan initiated by its controlling shareholder, Shanghai Industrial (Group) Co., Ltd., reflecting confidence in the company's future development and value recognition [1][2]. Group 1: Buyback Plan Details - The buyback plan was disclosed on September 14, 2024, with a duration from September 13, 2024, to September 12, 2025, allowing for a maximum increase of 2% of the company's total voting rights [2][3]. - As of June 25, 2025, the controlling shareholder has acquired a total of 74,000,000 H shares, representing approximately 8.052% of the total issued H shares and 1.995% of the total issued shares [1][3]. Group 2: Shareholding Structure Post-Buyback - After the completion of the buyback, the controlling shareholder holds a total of 1,426,255,837 shares, accounting for approximately 38.461% of the total issued shares, with 300,438,000 H shares representing about 32.689% of the total issued H shares [1][2]. - The buyback did not involve any reduction in the shares held by the controlling shareholder during the buyback period [1].